Compound information
- Natural Products
- ZC449290
- Molecular Formula
- C15H19NO3
- Molecular Weight
- 261.136493468 g/mol
- Structure
-
- IUPAC Name
- ethyl (2S)-1-benzyl-3-oxo-piperidine-2-carboxylate
- InChI
- InChI=1S/C15H19NO3/c1-2-19-15(18)14-13(17)9-6-10-16(14)11-12-7-4-3-5-8-12/h3-5,7-8,14H,2,6,9-11H2,1H3/t14-/m0/s1
- InChI Key
- HHLLUOKPRLDZNL-AWEZNQCLSA-N
- SMILES
- CCOC(=O)[C@@H]1C(=O)CCCN1Cc1ccccc1
- Source
- ZINC000148335216
Warheads
- Carbonyl
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 19 | Ring Count | 2 |
| Heteroatom Count | 4 | Rotatable Bond Count | 4 |
| Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
| Topological Polar Surface Area | 46.61 Å2 | LogP | 1.872 |
| LogS | -1.985 | LogD | 0.858 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.021 | Pgp substrate | 0.066 |
| HIA | 0.963 | F20 % | 0.989 |
| F30 % | 0.735 | Caco-2 | -4.699 |
| MDCK | -4.328 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.096 | PPB | 54.186 |
| VD | 1.754 | Fu | 0.377 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.622 |
| CYP2A6 substrate | 0.718 | CYP2B6 substrate | 0.878 |
| CYP2C19 inhibitor | 0.193 | CYP2C19 substrate | 0.942 |
| CYP2C8 substrate | 0.692 | CYP2C9 inhibitor | 0.113 |
| CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.017 |
| CYP2D6 substrate | 0.932 | CYP2E1 substrate | 0.226 |
| CYP3A4 inhibitor | 0.019 | CYP3A4 substrate | 0.9 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.959 | CL | 15.172 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.296 | Hepatotoxicity | 0.507 |
| Mutagenicity | 0.003 | Rat Oral Acute Toxicity | 0.114 |
| FDAMDD | 0.583 | Skin Sensitization | 0.183 |
| Carcinogenicity | 0.027 | Eye Corrosion | 0.002 |
| Eye Irritation | 0.581 | Respiratory Toxicity | 0.42 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | -0.059 | IGC50 | 2.733 |
| LC50FM | 3.232 | LC50DM | 3.318 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.302 | NR-AR-LBD | 0.31 |
| NR-AhR | 0.004 | NR-Aromatase | 0.029 |
| NR-ER | 0.334 | NR-ER-LBD | 0.337 |
| NR-PPAR-gamma | 0.208 | SR-ARE | 0.03 |
| SR-ATAD5 | 0.33 | SR-HSE | 0.064 |
| SR-MMP | 0.007 | SR-p53 | 0.017 |
Similar covalent drugs
No similar covalent drugs found for this compound.